CSTL Stock-Based Compensation
Castle Biosciences Inc · Stock-Based Compensation
CSTL Stock-Based Compensation
Latest reported$44.87Mperiod ending
CSTL Stock-Based Comp ($108.70K → $44.87M)
Annual stock-based compensation
High-resolution chart · PNG
CSTL stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 45,893,000 | |
| 50,320,000 | |
| 51,219,000 | |
| 36,321,000 | |
| 21,740,000 | |
| 8,309,000 | |
| 1,249,000 | |
| 293,639 | |
| 108,696 |